Original Research
Published on 15 May 2026
Neoadjuvant camrelizumab in combination with chemotherapy followed by sequential radical surgery for locally advanced esophageal squamous cell carcinoma: postoperative pathological remission characteristics and influencing factors
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
- 486 views